Advanced ovarian cancer treated in pregnancy and detected by cell-free DNA aneuploidy screening

• Abnormal cell free DNA results may indicate occult maternal malignancy. • Cesarean-cytoreductive surgery is feasible even with significant disease burden. • Carboplatin/paclitaxel is first line for epithelial ovarian cancer in pregnancy.

Detalles Bibliográficos
Autores principales: Cordeiro Mitchell, Christina N., Murdock, Tricia, Fader, Amanda N., Stone, Rebecca L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6003407/
https://www.ncbi.nlm.nih.gov/pubmed/29915798
http://dx.doi.org/10.1016/j.gore.2018.03.006
Descripción
Sumario:• Abnormal cell free DNA results may indicate occult maternal malignancy. • Cesarean-cytoreductive surgery is feasible even with significant disease burden. • Carboplatin/paclitaxel is first line for epithelial ovarian cancer in pregnancy.

Ejemplares similares